Veeva Systems Inc. operates primarily through two main product areas: Veeva Commercial Cloud and Veeva Development Cloud (Veeva Vault). The Commercial Cloud suite provides customer relationship management (CRM), data, and analytics solutions designed to optimize sales and marketing efforts for pharmaceutical brands. The Development Cloud features enterprise content and data management applications that streamline research and development, clinical trial execution, regulatory submissions, and safety monitoring. Geographically, Veeva serves a global client base across North America, Europe, the Asia Pacific, and Latin America. The company's competitive advantage lies in its specialized, industry-specific architecture that ensures strict regulatory compliance and traceability, replacing legacy on-premise systems with modern Software-as-a-Service (SaaS) platforms. In 2021, Veeva became the first publicly traded company to convert to a Public Benefit Corporation, emphasizing its commitment to balancing shareholder interests with societal impact.
